Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
Andreas Wasilewicz, Benjamin Kirchweger, Denisa Bojková, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 2, pp. 264-275
Open Access | Times Cited: 23

Showing 23 citing articles:

Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 6
In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations
Takeshi Ishikawa, Kenji Matsumoto, Toshiyuki Hamada, et al.
The Journal of Physical Chemistry B (2025) Vol. 129, Iss. 6, pp. 1740-1749
Closed Access
Ouratein D, a Biflavanone From Ouratea spectabilis, Alleviates Betacoronavirus Infection by Mitigating Inflammation, Lung Damage and Viral Replication
A. Monteiro, Kátia Michelle Freitas, Ana Clara M. Montuori‐Andrade, et al.
Phytotherapy Research (2025)
Closed Access
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Comprehensive overview of different medicinal parts from Morus alba L.: chemical compositions and pharmacological activities
Yumei Wang, Qing Ai, GU Mei-ling, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective
Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, et al.
Gene (2024) Vol. 922, pp. 148553-148553
Closed Access | Times Cited: 3
Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking
Andreas Wasilewicz, Julia Zwirchmayr, Benjamin Kirchweger, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies
Andreas Wasilewicz, Denisa Bojková, Mehdi A. Beniddir, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117206-117206
Closed Access | Times Cited: 5
Antiviral miliusanes and isolation of an unprecedented miliusane dimer from Miliusa balansae
Bastien Petit, Élodie Marguerite, Elsa Van Elslande, et al.
Fitoterapia (2024) Vol. 177, pp. 106083-106083
Closed Access | Times Cited: 1
How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116788-116788
Closed Access | Times Cited: 1
Core publications in drug discovery and natural product research
Banaz Jalil, Judith M. Rollinger, Atanas G. Atanasov, et al.
Frontiers in Natural Products (2024) Vol. 3
Open Access | Times Cited: 1
A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3
Protease inhibitors from Theobroma cacao impair SARS-CoV-2 replication in vitro
Brenda Conceição Guimarães Santana, Daisymara Priscila de Almeida Marques, Andria dos Santos Freitas, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15860-e15860
Open Access | Times Cited: 2
Correlation of bioactive marker compounds of an orally applied Morus alba root bark extract with toxicity and efficacy in BALB/c mice
Julia Langeder, Mirijam Koch, Hannes Schmietendorf, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Investigating the bispecific lead compounds against methicillin-resistant Staphylococcus aureus SarA and CrtM using machine learning and molecular dynamics approach
Kareem M. Younes, Amr S. Abouzied, Ahmed Alafnan, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Closed Access | Times Cited: 2
Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration
Jacqueline Schwarzinger, Sigrid Adelsberger, Karin Ortmayr, et al.
International Journal of Pharmaceutics X (2024) Vol. 8, pp. 100272-100272
Open Access
The potential of natural products for the suppression of SARS-CoV-2 replication
Shoichi Sanuki, Mona Tagawa, Rieko Saito, et al.
Studies in natural products chemistry (2024), pp. 1-68
Closed Access
Investigating the impact of SOD1 mutations on amyotrophic lateral sclerosis progression and potential drug repurposing through in silico analysis
A. Khuzaim Alzahrani, Mohd Imran, Ahmed Subeh Alshrari
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-16
Closed Access
A Combination of Structure-based Virtual Screening and Experimental Strategies to Identify the Potency of Caffeic Acid Ester Derivatives as SARS-CoV-2 3CLpro Inhibitor from an In-house Database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Research Square (Research Square) (2023)
Open Access
Synthesis and investigation of new indole‐containing vinyl sulfide derivatives: In silico and in vitro studies for potential therapeutic applications
Ana Paula Bonato Wille, Ketlyn P. da Motta, Nathan Pinto Brites, et al.
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access
Short Lecture "Optimisation and biochemometric analysis of Morus alba root bark extracts against acute respiratory infections"
Ulrike Grienke, Julia Langeder, Kristin Doering, et al.
Planta Medica (2023) Vol. 89, Iss. 14, pp. 1298-1299
Closed Access
Cheminformatic and biochemometric strategies for the discovery of natural products against SARS-CoV-2
Benjamin Kirchweger, Andreas Wasilewicz, Ulrike Grienke, et al.
Planta Medica (2023) Vol. 89, Iss. 14, pp. 1421-1421
Closed Access
Short Lecture “Spotlight on Morus alba root bark compounds and extracts in search of inhalable natural product formulations against acute respiratory infections”
Sigrid Adelsberger, Jacqueline Schwarzinger, Gabriela Hädrich, et al.
Planta Medica (2023) Vol. 89, Iss. 14, pp. 1278-1278
Closed Access
Page 1

Scroll to top